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ABSTRACT: The α′-acyloxylation of cyclic enones with
linear carboxylic acids is described. The reaction is promoted
by KMnO4 in the presence of a carboxylic acid and its
corresponding carboxylic anhydride. The optimization of the
reaction has been carried out using the statistical methodology
known as design of experiments. The optimized reaction
conditions have been evaluated in terms of substrate scope and
compatibility with different functional groups. The methodology has been applied to the synthesis of densely oxygenated
guaianes and guaianolides.
■ INTRODUCTION
In the last decades, different methodologies for the activation of
C−H bonds have emerged.1 Remarkable progress has been
made in the C(sp2)−H activation (aromatic or vinylic)2 and in
the oxidation of C(sp3)−H bonds at allylic positions.3 Another
interesting reaction involving the transformation of C(sp3)−H
bonds is the α-oxidation of a carbonyl group. This kind of
reaction has been the subject of research since many
biologically significant compounds bear either hydroxyl or
acyloxy groups in this position.4
In 1989, Watt et al. reported that enones could be
functionalized at the α′-position by treatment with Mn(OAc)3
in the presence of different carboxylic acids.5 The mechanism
involves the in situ generation of a radical Mn(III) carboxylate,
which reacts with the enone, leading to the corresponding α′-
acyloxyenone.6 Although good yields were reported, the
methodology presented some problems: (i) the need for a
large excess of the carboxylic acid and the Mn precursor, which,
in addition, had to be freshly prepared7 or dried prior to use;
(ii) the use of a Dean−Stark trap to remove the water, which
made scaling up or down the reaction difficult; and (iii) poor
functional group compatibility.
Demir et al. reported some improvements by using KMnO4
instead of Mn(OAc)3 to generate the Mn(III) species in situ.
8
Yet, the scope of the reaction was rather limited and the
application of this methodology to the synthesis of natural
products remained a challenge. References applying this
method into complex syntheses are lacking, and the
reproducibility issues and some contradictory results have
prevented this reaction to be included in the pool of
synthetically useful reactions.
Herein, we present our study and optimization of the α′-
acyloxylation of cyclic enones by KMnO4 in the presence of a
mixture of a carboxylic acid and its corresponding anhydride as
an effective water scavenger. The use of Dean−Stark apparatus
is no longer necessary, simplifying the scaling of the reaction.
The reaction conditions have been optimized using a design of
experiments (DoE) approach,9 which guarantees the robustness
of the method. The optimized reaction conditions have been
applied to the synthesis of several guaianes and guaianolides,
closely related to thapsigargin 1a and thapsigargicin 1b, two
compounds with remarkable anti-SERCA ATPase activity
(Figure 1).10
■ RESULTS AND DISCUSSION
In the seminal report by Watt, it was demonstrated that
removal of water was necessary for the reaction to proceed.5
When we first ran the reaction using small amounts of the
reactants, the Dean−Stark trap was not effective. The collected
solvent in the side arm of the trap was cloudy, but the amount
of water generated was too small to become an isolated
aqueous layer. To solve this problem and simplify the reaction
setup, we undertook an exploratory screening of methods to
remove efficiently the generated water. As a benchmark
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Figure 1. Thapsigargin 1a and thapsigargicin 1b.
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reaction, we chose the α′-acetoxylation of isophorone 3 to
produce 6-acetylisophorone 4. We considered five variables to
study: (i) time prior to the substrate addition, needed for the
formation of the radical Mn(III) carboxylate, (ii) temperature,
(iii) equivalents of KMnO4, (iv) equivalents of acetic acid, and
(v) amount of 4 Å molecular sieves. As illustrated in Table 1
(entries 1−6), the use of 4 Å molecular sieves resulted in poor
yields presumably due to the high temperature.11 Other
additives were also evaluated for the same role, among them
acetic anhydride. The reduction of Mn(VII) to Mn(III)
involves the formation of water.8 The use of a carboxylic
anhydride might favor the reaction by removing water and
serve as well as an acyloxy group source, along with the
carboxylic acid itself. As expected, higher yields were obtained
when acetic anhydride was used in conjunction with acetic acid
(entry 8, Table 1).
Since the actual mechanism of the reaction remained unclear,
we considered the use of a design of experiments (DoE)
approach for the optimization of the reaction to be convenient.
DoE is a statistical optimization method that explores an
experimental domain, setting up different variables or factors in
high, medium, and low levels. The influence of these variables is
thus studied, and the response (yield in our case) is optimized.
Instead of optimizing one variable at a time (an OVAT
approach), DoE performs the optimization of several variables
simultaneously. An algorithm suggests the conditions in which
the experiments have to be run. The response is evaluated, and
a model for the behavior of the system is obtained.9 The aim is
to get the maximum amount of information using the minimum
number of experiments.
Our model would take into account three variables: (i)
equivalents of KMnO4, (ii) equivalents of acetic acid, and (iii)
equivalents of acetic anhydride. To ensure the effective
formation of the radical Mn(III) carboxylate, the time prior
to the addition of the substrate and the temperature were set at
30 min and 85 °C, respectively. Finally, the substrate
concentration was kept at 0.04 M in benzene. We decided to
perform a Box−Behnken design (BBD), with three levels for
each variable (Table 2). The experiments were carried out
according to the matrix shown in Table 3. The yields were
measured, and a quadratic model was fitted for the reaction.
The variance of the method was estimated by running three
replicates of the central point (Table 3, entries 4, 8, 10, and 11).
According to the results, the optimal conditions were those
corresponding to 2.10 equiv of KMnO4, 35.0 equiv of acetic
Table 1. Screening of Conditions without a Dean−Stark Apparatusa
entry time prior to substrate addition (min) temp (°C) KMnO4 (equiv) AcOH (equiv) additive yield
b (%)
1 60 85 1.20 10 4 Å MS (0.060 g) 39
2 30 85 3.10 25 4 Å MS (0.230 g) 10
3 60 50 2.10 12 4 Å MS (0.230 g) 1
4 45 65 2.10 17 4 Å MS (0.140 g) 12
5 60 85 3.10 25 4 Å MS (0.230 g) 30
6 45 65 2.10 170 4 Å MS (0.140 g) 17
7 30 85 3.10 170 Na2SO4 (10 equiv) 37
8 30 85 3.10 170 Ac2O (100 equiv) 63
9 30 85 3.10 170 AcCl (100 equiv) 32
aReaction conditions: KMnO4, AcOH, additive, and PhH (4 mL) at the stated temperature and stir for the indicated time, then isophorone 3 (0.025
mL, 0.160 mmol) and stir overnight at the stated temperature. bDetermined by GC analysis.
Table 2. Selected Levels for Each Variable for BBD
levels
variables symbol low medium high
equiv of KMnO4 A 1.05 2.10 3.15
equiv of AcOH B 10.0 22.5 35.0
equiv of Ac2O C 5.00 9.50 14.0
Table 3. Design of Experiments Optimization for α′-
Acetyloxylation of Isophorone 3a,b
variables
A B C
run KMnO4 (equiv) AcOH (equiv) Ac2O (equiv) yield
c (%)
1 3.15 22.5 5.00 45
2 3.15 10.0 9.50 34
3 1.05 35.0 9.50 86
4 2.10 22.5 9.50 56
5 1.05 22.5 5.00 63
6 3.15 22.5 14.0 51
7 2.10 35.0 5.00 71
8 2.10 22.5 9.50 69
9 3.15 35.0 9.50 67
10 2.10 22.5 9.50 75
11 2.10 22.5 9.50 65
12 2.10 10.0 14.0 48
13 2.10 10.0 5.00 40
14 2.10 35.0 9.50 91
15 1.05 22.5 14.0 58
16 1.05 10.0 9.50 62
17 2.10 35.0 14.0 73
aReaction conditions: KMnO4 (variable A), AcOH (B), and Ac2O (C)
in the indicated amounts, and PhH (4 mL) at 85 °C for 30 min, then
isophorone 3 (0.025 mL, 0.160 mmol), stirring at 85 °C overnight.
bRuns displayed in the order determined by the Box−Behnken matrix.
cDetermined by GC analysis.
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acid, and 9.50 equiv of acetic anhydride, which afforded a 91%
yield by GC analysis (entry 14, Table 3; 100% isolated yield).
As an alternative to the use of benzene, other solvents were
evaluated. Moderate yields were obtained with dichloroethane
(62%) and toluene (59%). Cyclohexene and acetonitrile
afforded lower yields (45% and 35%, respectively).
The obtained model is illustrated by the calculated response
surface (Figure 2), which represents the dependence of the
yield on the studied variables. An inspection of Figure 2 shows
that, for an intermediate level of KMnO4, the combination of
an intermediate level of acetic anhydride with high levels of
acetic acid would lead to higher responses. In addition, the
Pareto plot confirms the influence of the acetic anhydride in the
system, since its quadratic effect (CC) is significant at 90%
confidence (Figure 3). Other interaction effects among
variables (AA, AC, AB, BC, and BB) were not significant. As
expected, higher amounts of acetic acid lead to higher yields.
The statistical significance of the model was evaluated by
analysis of variance (ANOVA) and the calculation of the
coefficient of determination R2 (Table 4). Although the F value
of the model, 3.46, was not high enough to ensure significance
at 90% confidence (F was lower than the critical F value, 3.90),
the R2 coefficient was 0.9122, which implied a good fit between
predicted and experimental data. The model explained the
95.51% of the variance. Furthermore, the F value for the lack of
fit, 2.49 (<Fc), indicated that it was not significant relative to
pure error. These results allowed us to consider the model as
robust and the obtained optimal conditions as reproducible.
The scope of the reaction was further investigated. Several
substrates and linear carboxylic acids with chains of different
lengths (2, 4, 6, and 8 carbon atoms) were selected (Table 5).
The yields ranged from good to excellent, but no trend
attributable to the substrate or the chain length was observed.
We next turned to study the reaction with more complex
substrates. Guaianes constitute a widely distributed group of
sesquiterpenes, many of which bear a cyclopentenone system.
Most guaianolides isolated from Umbelliferae plants display an
acyl group located at the C-2 carbon atom, which we envisaged
that could be set by α′-oxidation of a ketone previously located
at C-3. They seemed a suitable scaffold for the testing of the
reaction in a more complex environment. We then decided to
test guaianolide 21 and guaiane 25 as substrates for this
methodology.
O-Acetylisophotosantonic lactone 21 was easily prepared by
photochemical rearrangement in 38% yield from α-santonin 20
using AcOH as the solvent (Scheme 1a).12 On the other hand,
guaiane 25 is an intermediate that can be prepared by following
a methodology that we devised for the synthesis of analogues of
thapsigargin.13 To this end, compound 23 was subjected to
photochemical rearrangement in AcOH, providing 24 in 72%
yield. Subsequent protection of the primary hydroxyl group
with TBDMSCl and imidazole afforded guaiane 25 in almost
quantitative yield (Scheme 1b).
The behavior of compounds 21 and 25 under the oxidation
conditions demonstrated the tolerance of the reaction to the
presence of different functional groups such as lactones, esters,
double bonds, and silyl protected hydroxyl groups (Table 6).
The reaction outcome was affected by substrate stereochemical
control, since one single diastereomer was detected in all cases.
Structural features in derivatives 26−29 make them interesting
from a biological perspective since many sesquiterpene lactones
are lead compounds in drug discovery.14
Our interest in bioactive guaianolides prompted us to apply
this methodology to the synthesis of new analogues of
thapsigargin 1a and thapsigargicin 1b. There is just one
reported total synthesis of thapsigargin and several members of
the family by Ley et al.15 Some unnatural derivatives have been
also synthesized by the same authors.16 Currently, a prodrug17
against prostate cancer based on thapsigargin is being tested in
clinical trials.18 The remarkable biological activities of
thapsigargin and related compounds and the scarcity of
methods for their preparation make the opening of new routes
of synthesis interesting.
Compound 33 could be conveniently modified to provide
thapsigargin analogues (Scheme 2). To this end, 33 was
prepared from 25 on a 1 g scale with good yield (see the
Experimental Section). Then, it was submitted to TBAF
Figure 2. Calculated response surface for the yield of 4 (medium level
of KMnO4, 2.10 equiv).
Figure 3. Pareto plot for standard effects over the yield of 4.
Table 4. ANOVA Results of the Quadratic Model for the Yield of 4a
source sum of squares degree of freedom mean squares F values Fc values
total 3861.87 16
model 3522.67 12 293.56 3.46 3.90
residual 339.20 4 84.80
lack of fit 153.86 1 153.86 2.49 5.54
pure error 185.35 3 61.78
aR2 = 0.9122; R = 0.9551. 95.51% of the variance explained by the model.
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deprotection, affording diol 34 in 61% yield. Treatment of 34
with NMO in the presence of catalytic OsO4 produced the
dihydroxylation of the C6−C7 double bond, providing tetrol
35, whose purification resulted to be troublesome. The
unpurified tetrol 35 was treated with the TEMPO/NaClO/
NaClO2 oxidation system, leading to guaianolide 36 in 65%
yield (two steps). Guaianolide 36 displays six out of the eight
chiral centers found in thapsigargin, thus becoming an
interesting model for biological testing.
■ CONCLUSION
We have demonstrated that the use of KMnO4 in the presence
of a carboxylic acid and its corresponding anhydride is a valid
method to perform the introduction of an acyl moiety at the α′-
position of a carbonyl group, enabling the functionalization of
hindered enones. The presence of a carboxylic anhydride makes
the use of molecular sieves or a Dean−Stark trap to remove the
water unnecessary. In addition, the existence of modern
statistics software packages makes the DoE analysis available
as a tool for the optimization of chemical reactions. The
developed conditions have allowed us to prepare highly
oxygenated guaianes and guaianolides that can serve as
thapsigargin analogues. Further applications to the synthesis
of guaianolide derivatives and their biological evaluation are
currently in progress.
■ EXPERIMENTAL SECTION
General Methods. HPLC purification was carried out using a 1 ×
25 cm silica gel column (LiChrosorb Si 60, 7 μm particle size). GC
analyses were performed using a DB-5 column. NMR spectra were
recorded on a 400 or 500 MHz spectrometer using standard pulse
sequences. Spectra were referenced internally to residual solvent
signals (CHCl3, δ = 7.26 ppm for
1H NMR, δ = 77.16 ppm for 13C
NMR). Mass spectra were recorded in a UPLC-QTOF mass
spectrometer.
Design of Experiments Optimization (Table 3). All experi-
ments were carried out simultaneously in a parallel synthesis carrousel.
In each vessel, KMnO4 (amounts according to Table 3) was vigorously
Table 5. Scope of the Reaction of α′-Acyloxylation of Enonesa,b
aReaction conditions: KMnO4 (83 mg, 0.525 mmol, 2.10 equiv), carboxylic acid (35.0 equiv), and carboxylic anhydride (9.50 equiv) in PhH (6.25
mL) at 85 °C for 30 min, then substrate (0.250 mmol) addition and stirring overnight at 85 °C. bIsolated yields determined after flash column
chromatography.
Scheme 1. Preparation of Starting Materials 21 and 25
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stirred in dry benzene (3 mL). The mixture was heated at 85 °C, and
the corresponding amounts of acetic acid and acetic anhydride were
added. After 30 min, the color changed from purple to brown and a
solution of isophorone 3 (0.025 mL, 0.160 mmol) and octadecane
(GC internal standard, 5 mg) in dry benzene (1 mL) was added to
each vessel. Reactions were vigorously stirred overnight at 85 °C. To
determine yields by GC, aliquots from the reaction mixture were
taken, filtered through silica gel, and analyzed by GC.
Typical Procedure for α′-Acyloxylation of Enones (Tables 5
and 6). To a suspension of KMnO4 (83 mg, 0.525 mmol, 2.10 equiv)
in dry benzene (6.25 mL, 0.04 M in enone) at 85 °C were added the
corresponding carboxylic acid (8.750 mmol, 35.0 equiv) and its
anhydride (2.375 mmol, 9.50 equiv). The mixture was vigorously
stirred until the suspension changed from purple to brown (30 min),
and then, the enone (0.250 mmol) was added (directly by syringe or
dissolved in the minimum amount of dry benzene). Vigorous stirring
of the reaction was continued at 85 °C overnight, then cooled to room
temperature, and filtered through an Al2O3/Celite pad rinsing with
EtOAc. The solvent was evaporated under reduced pressure, and the
crude oil was purified by flash column chromatography with EtOAc/
hexanes mixtures as eluents to lead to products in yields according to
Tables 5 and 6.
6-Acetyloxy-3,5,5-trimethylcyclohex-2-enone (4). Yellow oil
(49 mg, 100%); 1H NMR (500 MHz, CDCl3) δ 5.87 (br s, 1H), 5.18
(s, 1H), 2.50 (d, J = 18.4 Hz, 1H), 2.17 (s, 3H), 2.15 (d, J = 16.2 Hz,
1H), 1.92 (s, 3H), 1.06 (s, 3H), 0.95 (s, 3H); 13C NMR (126 MHz,
CDCl3) δ 193.2, 170.6, 159.5, 124.7, 80.6, 46.1, 37.7, 27.3, 24.4, 20.8,
20.0; IR (film) νmax 2970, 2933, 1749, 1688, 1634, 1380, 1234, 1069




oil (50 mg, 89%); 1H NMR (400 MHz, CDCl3) δ 5.89 (br s, 1H), 5.22
(s, 1H), 2.53 (d, J = 18.4 Hz, 1H), 2.45 (m, 2H), 2.17 (d, J = 18.4 Hz,
1H), 1.94 (s, 3H), 1.73 (tq, J = 7.4, 7.4 Hz, 2H), 1.08 (s, 3H), 1.00 (t, J
= 7.4 Hz, 3H), 0.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 193.4,
173.3, 159.3, 124.9, 80.4, 46.2, 37.9, 36.2, 27.4, 24.4, 20.1, 18.9, 13.8;
IR (film) νmax 2968, 2937, 2876, 1743, 1688, 1636, 1381, 1238, 1176,




oil (51 mg, 81%); 1H NMR (400 MHz, CDCl3) δ 5.88 (br s, 1H), 5.20
(s, 1H), 2.51 (d, J = 19.1 Hz, 1H), 2.45 (m, 2H), 2.16 (d, J = 18.4 Hz,
1H), 1.93 (s, 3H), 1.64 (tt, J = 7.5, 7.4 Hz, 2H), 1.34 (m, 4H), 1.06 (s,
3H), 0.96 (s, 3H), 0.88 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 193.3, 173.4, 159.3, 124.8, 80.3, 46.2, 37.8, 34.2, 31.4, 27.4,
24.8, 24.4, 22.4, 20.1, 14.0; IR (film) νmax 2961, 2934, 2873, 1744,
1690, 1634, 1380, 1238, 1169, 1059 cm−1; HRMS (APGC) calcd. for
C15H25O3 [M + H]
+ 253.1804; found 253.1808.
3,5,5-Trimethyl-6-octanoyloxycyclohex-2-enone (7). Yellow
oil (46 mg, 66%); 1H NMR (400 MHz, CDCl3) δ 5.89 (br s, 1H), 5.21
(s, 1H), 2.52 (d, J = 18.4 Hz, 1H), 2.45 (m, 2H), 2.16 (d, J = 18.4 Hz,
1H), 1.93 (s, 3H), 1.68 (tt, J = 7.5, 7.4 Hz, 2H), 1.31 (m, 8H), 1.07 (s,
3H), 0.97 (s, 3H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 193.3, 173.4, 159.3, 124.9, 80.3, 46.2, 37.8, 34.3, 31.8, 29.2,
29.1, 27.4, 25.2, 24.4, 22.7, 20.1, 14.2; IR (film) νmax 2958, 2931, 2858,
1745, 1690, 1637, 1380, 1165, 1065 cm−1; HRMS (APGC) calcd. for
C17H29O3 [M + H]
+ 281.2117; found 281.2108.
6-Acetyloxy-3-methylcyclohex-2-enone (8). Yellow oil (30 mg,
71%); 1H NMR (500 MHz, CDCl3) δ 5.90 (br s, 1H), 5.29 (br s, 1H),
2.55 (m, 1H), 2.39 (br d, J = 18.7 Hz, 1H), 2.23 (m, 1H), 2.16 (s, 3H),
2.09 (m, 1H), 1.96 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 193.6,
Table 6. Scope of the Reaction over Guaianolide and Guaiane Scaffoldsa,b
aReaction conditions: KMnO4 (83 mg, 0.525 mmol, 2.10 equiv), carboxylic acid (35.0 equiv), and carboxylic anhydride (9.50 equiv) in PhH (6.25
mL) at 85 °C for 30 min, then substrate (0.250 mmol) and stir at 85 °C overnight. bIsolated yields determined after flash column chromatography.
Scheme 2. Synthesis of Compound 36 from 33
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170.4, 162.4, 125.5, 73.2, 30.5, 28.4, 24.3, 21.0; IR (film) νmax 2936,
1747, 1690, 1380, 1238, 1208, 1168 cm−1; HRMS (APGC) calcd. for
C9H13O3 [M + H]
+ 169.0865; found 169.0868.
6-Butanoyloxy-3-methylcyclohex-2-enone (9). Yellow oil (27
mg, 56%); 1H NMR (500 MHz, CDCl3) δ 5.90 (br s, 1H), 5.31 (dd, J
= 13.3, 5.3 Hz, 1H), 2.55 (m, 1H), 2.40 (m, 3H), 2.22 (dddd, J = 7.8,
7.8, 5.2, 2.6 Hz, 1H), 2.09 (dddd, J = 17.1, 12.7, 12.7, 5.2 Hz, 1H),
1.97 (s, 3H), 1.70 (tq, J = 7.4, 7.4 Hz, 2H), 0.97 (t, J = 7.4 Hz, 3H);
13C NMR (126 MHz, CDCl3) δ 193.7, 173.0, 162.3, 125.6, 72.9, 36.2,
30.6, 28.4, 24.3, 18.6, 13.7; IR (film) νmax 2966, 2936, 2876, 1743,
1689, 1633, 1381, 1177, 1104 cm−1; HRMS (APGC) calcd. for
C11H17O3 [M + H]
+ 197.1178; found 197.1178.
6-Hexanoyloxy-3-methylcyclohex-2-enone (10). Yellow oil
(37 mg, 66%); 1H NMR (400 MHz, CDCl3) δ 5.89 (br s, 1H),
5.30 (dd, J = 13.3, 5.4 Hz, 1H), 2.55 (m, 1H), 2.40 (m, 3H), 2.21
(dddd, J = 7.8, 7.8, 5.2, 2.6 Hz, 1H), 2.08 (dddd, J = 16.9, 13.2, 11.7,
5.2 Hz, 1H), 1.96 (s, 3H), 1.66 (tt, J = 7.7, 7.7 Hz, 2H), 1.33 (m, 4H),
0.88 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 193.7, 173.2,
162.3, 125.6, 72.9, 34.3, 31.4, 30.5, 28.4, 24.7, 24.2, 22.4, 14.0; IR
(film) νmax 2956, 2933, 2872, 1743, 1690, 1633, 1380, 1208, 1167,
1103 cm−1; HRMS (APGC) calcd. for C13H21O3 [M + H]
+ 225.1491;
found 225.1505.
3-Methyl-6-octanoyloxycyclohex-2-enone (11). Yellow oil (47
mg, 74%); 1H NMR (400 MHz, CDCl3) δ 5.90 (br s, 1H), 5.31 (dd, J
= 13.3, 5.4 Hz, 1H), 2.55 (m, 1H), 2.39 (m, 3H), 2.22 (dddd, J = 7.8,
7.8, 5.2, 2.6 Hz, 1H), 2.09 (dddd, J = 16.9, 11.8, 11.8, 5.2 Hz, 1H),
1.97 (s, 3H), 1.67 (tt, J = 7.1, 7.1 Hz, 2H), 1.31 (m, 8H), 0.87 (t, J =
6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 193.7, 173.2, 162.3,
125.6, 72.9, 34.3, 31.8, 30.6, 29.2, 29.1, 28.4, 25.0, 24.3, 22.7, 14.2; IR
(film) νmax 2930, 2856, 1743, 1691, 1633, 1380, 1162, 1105 cm
−1;




low oil (45 mg, 81%); 1H NMR (400 MHz, CDCl3) δ 5.11 (dd, J =
6.9, 3.0 Hz, 1H), 2.97 (dd, J = 18.0, 6.9 Hz, 1H), 2.42 (br d, J = 18.0
Hz, 1H), 2.18 (m, 2H), 2.12 (s, 3H), 2.05 (s, 3H), 1.38 (m, 2H), 1.28
(m, 4H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
203.3, 170.8, 167.4, 139.6, 71.9, 38.9, 31.8, 28.0, 23.1, 22.6, 21.0, 17.3,
14.1; IR (film) νmax 2931, 2860, 1746, 1714, 1373, 1229, 1056 cm
−1;




Yellow oil (22 mg, 35%); 1H NMR (500 MHz, CDCl3) δ 5.12 (dd,
J = 6.9, 3.0 Hz, 1H), 2.97 (dd, J = 18.0, 6.9 Hz, 1H), 2.36 (m, 3H),
2.18 (m, 2H), 2.05 (s, 3H), 1.67 (tq, J = 7.4, 7.1 Hz, 2H), 1.39 (tt, J =
7.8, 7.8 Hz, 2H), 1.27 (m, 4H), 0.96 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 7.1
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 203.3, 173.4, 167.2, 139.6,
71.8, 38.9, 36.0, 31.8, 28.0, 23.1, 22.6, 18.5, 17.3, 14.1, 13.7; IR (film)
νmax 2959, 2932, 2874, 1743, 1714, 1643, 1388, 1174, 1055 cm
−1;




Yellow oil (52 mg, 74%); 1H NMR (400 MHz, CDCl3) δ 5.11 (dd,
J = 6.9, 3.1 Hz, 1H), 2.96 (dd, J = 18.0, 6.9 Hz, 1H), 2.36 (m, 3H),
2.18 (m, 2H), 2.05 (s, 3H), 1.64 (tt, J = 7.5, 7.5 Hz, 2H), 1.38 (m,
2H), 1.27 (m, 8H), 0.88 (m, 6H); 13C NMR (100 MHz, CDCl3) δ
203.3, 173.6, 167.1, 139.6, 71.8, 38.9, 34.2, 31.8, 31.4, 28.0, 24.7, 23.1,
22.6, 22.4, 17.3, 14.1, 14.0; IR (film) νmax 2956, 2931, 2859, 1743,
1715, 1643, 1388, 1164, 1112 cm−1; HRMS (APGC) calcd. for
C17H29O3 [M + H]
+ 281.2117; found 281.2126.
3-Methyl-5-octanoyloxy-2-pentylcyclopent-2-enone (15).
Yellow oil (42 mg, 54%); 1H NMR (500 MHz, CDCl3) δ 5.11 (dd,
J = 6.9, 3.0 Hz, 1H), 2.96 (dd, J = 18.0, 6.9 Hz, 1H), 2.36 (m, 3H),
2.18 (m, 2H), 2.04 (s, 3H), 1.63 (tt, J = 7.8, 7.8 Hz, 2H), 1.38 (tt, J =
7.6, 7.6 Hz, 2H), 1.26 (m, 12H), 0.86 (m, 6H); 13C NMR (126 MHz,
CDCl3) δ 203.3, 173.6, 167.1, 139.6, 71.7, 38.9, 34.2, 31.8, 31.7, 29.2,
29.0, 28.0, 25.0, 23.1, 22.7, 22.6, 17.3, 14.2, 14.1; IR (film) νmax 2956,
2929, 2858, 1745, 1716, 1645, 1387, 1162, 1110 cm−1; HRMS
(APGC) calcd. for C19H33O3 [M + H]
+ 309.2430; found 309.2458.
6-Acetyloxy-3-ethoxycyclohex-2-enone (16). Yellow oil (29
mg, 59%); 1H NMR (400 MHz, CDCl3) δ 5.36 (s, 1H), 5.28 (dd, J =
12.6, 5.2 Hz, 1H), 3.90 (m, 2H), 2.64 (ddd, J = 17.1, 12.0, 5.1 Hz,
1H), 2.49 (ddd, J = 17.8, 5.3, 2.9 Hz, 1H), 2.21 (dddd, J = 10.4, 5.2,
4.6, 3.0 Hz, 1H), 2.16 (s, 3H), 2.08 (dddd, J = 17.6, 12.5, 12.5, 5.3 Hz,
1H), 1.36 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 193.3,
176.8, 170.5, 101.4, 72.6, 65.0, 28.1, 26.9, 21.1, 14.2; IR (film) νmax
2984, 1741, 1673, 1602, 1378, 1236, 1191, 1046 cm−1; HRMS
(APGC) calcd. for C10H15O4 [M + H]
+ 199.0970; found 199.0986.
6-Butanoyloxy-3-ethoxycyclohex-2-enone (17). Yellow oil (48
mg, 85%); 1H NMR (400 MHz, CDCl3) δ 5.33 (s, 1H), 5.27 (dd, J =
12.5, 5.3 Hz, 1H), 3.88 (m, 2H), 2.63 (ddd, J = 17.4, 11.9, 5.2 Hz,
1H), 2.47 (ddd, J = 17.8, 5.3, 3.2 Hz, 1H), 2.37 (m, 2H), 2.18 (dddd, J
= 8.3, 8.3, 5.2, 3.0 Hz, 1H), 2.06 (dddd, J = 17.7, 12.4, 12.4, 5.3 Hz,
1H), 1.68 (tq, J = 7.4, 7.0 Hz, 2H), 1.34 (t, J = 7.0 Hz, 3H), 0.95 (t, J =
7.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 193.3, 176.6, 173.0,
101.4, 72.3, 64.9, 36.1, 28.1, 26.9, 18.5, 14.1, 13.7; IR (film) νmax 2966,
2940, 2877, 1743, 1678, 1605, 1380, 1187, 1101 cm−1; HRMS
(APGC) calcd. for C12H19O4 [M + H]
+ 227.1283; found 227.1295.
3-Ethoxy-6-hexanoyloxycyclohex-2-enone (18). Yellow oil
(51 mg, 81%); 1H NMR (500 MHz, CDCl3) δ 5.35 (s, 1H), 5.27
(dd, J = 12.6, 5.2 Hz, 1H), 3.89 (m, 2H), 2.63 (ddd, J = 17.5, 12.0, 5.1,
Hz, 1H), 2.48 (ddd, J = 17.8, 5.2, 2.9 Hz, 1H), 2.39 (m, 2H), 2.19
(dddd, J = 8.2, 8.2, 5.2, 3.0 Hz, 1H), 2.07 (dddd, J = 17.8, 12.5, 12.5,
5.3 Hz, 1H), 1.66 (tt, J = 7.6, 7.6 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H),
1.31 (m, 4H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3)
δ 193.3, 176.7, 173.2, 101.4, 72.3, 65.0, 34.3, 31.3, 28.1, 26.9, 24.7,
22.4, 14.2, 14.0; IR (film) νmax 2954, 2933, 2872, 1744, 1667, 1604,
1379, 1196, 1169 cm−1; HRMS (APGC) calcd. for C14H23O4 [M +
H]+ 255.1596; found 255.1596.
3-Ethoxy-6-octanoyloxycyclohex-2-enone (19). Yellow oil (61
mg, 86%); 1H NMR (400 MHz, CDCl3) δ 5.35 (s, 1H), 5.27 (dd, J =
12.5, 5.2 Hz, 1H), 3.88 (m, 2H), 2.63 (ddd, J = 17.4, 11.9, 5.0 Hz,
1H), 2.48 (ddd, J = 17.6, 5.1, 2.8 Hz, 1H), 2.40 (m, 2H), 2.19 (dddd, J
= 8.3, 8.3, 5.2, 3.0 Hz, 1H), 2.07 (dddd, J = 17.8, 12.3, 12.3, 5.3 Hz,
1H), 1.65 (tt, J = 7.2, 7.4 Hz, 2H), 1.34 (t, J = 7.0 Hz, 3H), 1.28 (m,
8H), 0.85 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 193.3,
176.7, 173.2, 101.4, 72.3, 64.9, 34.3, 31.7, 29.1, 29.0, 28.1, 26.9, 25.0,
22.7, 14.2, 14.1; IR (film) νmax 2951, 2917, 2852, 1744, 1661, 1605,





yl Acetate (26). White amorphous solid (55 mg, 60%); [α]D
20 +45.33
(c 1.16, CHCl3);
1H NMR (500 MHz, CDCl3) δ 5.13 (d, J = 3.4 Hz,
1H), 4.83 (br d, J = 11.0 Hz, 1H), 4.05 (br s, 1H), 2.60 (ddd, J = 18.1,
13.6, 4.4 Hz, 1H), 2.28 (m, 3H), 2.14 (m, 1H), 2.09 (s, 3H), 2.06 (m,
1H), 1.95 (s, 3H), 1.95 (s, 3H), 1.46 (dddd, J = 14.8, 13.6, 11.3, 3.7
Hz, 1H), 1.27 (d, J = 6.9 Hz, 3H), 1.24 (s, 3H); 13C NMR (126 MHz,
CDCl3) δ 201.1, 176.7, 170.5, 169.8, 157.7, 140.6, 84.7, 81.1, 73.7,
52.5, 48.6, 41.3, 37.9, 25.7, 22.6, 20.8, 20.7, 12.6, 10.1; IR (film) νmax
2931, 1784, 1728, 1235, 1017, 753 cm−1; HRMS (APGC) calcd. for
C19H25O7 [M + H]
+ 365.1600; found 365.1612.
(3S,3aS,6R,6aS,7R,9bS)-7-Butanoyloxy-3,6,9-trimethyl-2,8-
dioxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-6-
yl Acetate (27). White amorphous solid (60 mg, 61%); [α]D
20 +90.95
(c 2.86, CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.11 (d, J = 3.2 Hz,
1H), 4.82 (br d, J = 11.0 Hz, 1H), 4.04 (br s, 1H), 2.59 (ddd, J = 18.0,
13.6, 4.4 Hz, 1H), 2.30 (m, 3H), 2.23 (t, J = 3.6 Hz, 1H), 2.15 (m,
1H), 2.06 (m, 1H), 1.94 (s, 3H), 1.93 (s, 3H), 1.64 (tq, J = 7.5, 7.5 Hz,
2H), 1.45 (dddd, J = 14.6, 14.6, 11.2, 3.6 Hz, 1H), 1.25 (d, J = 6.9 Hz,
3H), 1.23 (s, 3H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 201.2, 176.7, 172.5, 170.5, 157.8, 140.6, 84.6, 81.1, 73.6,
52.5, 48.5, 41.3, 37.9, 35.7, 25.6, 22.6, 20.8, 18.3, 13.7, 12.6, 10.1; IR
(film) νmax 2967, 2876, 1785, 1724, 1250, 1171, 997 cm
−1; HRMS
(APGC) calcd. for C21H29O7 [M + H]
+ 393.1913; found 393.1904.
(3S,3aS,6R,6aS,7R,9bS)-7-Hexanoyloxy-3,6,9-trimethyl-2,8-
dioxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-6-
yl Acetate (28). White amorphous solid (67 mg, 64%); [α]D
20 +50.97
(c 0.42, CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.10 (d, J = 3.1 Hz,
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1H), 4.82 (br d, J = 11.0 Hz, 1H), 4.05 (br s, 1H), 2.60 (ddd, J = 18.0,
13.6, 4.4 Hz, 1H), 2.31 (m, 3H), 2.25 (m, 1H), 2.15 (m, 1H), 2.06 (m,
1H), 1.94 (s, 3H), 1.93 (s, 3H), 1.61 (tt, J = 7.1, 7.1 Hz, 2H), 1.45
(dddd, J = 14.6, 14.6, 11.2, 3.6 Hz, 1H), 1.31 (m, 4H), 1.25 (d, J = 6.9
Hz, 3H), 1.23 (s, 3H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 201.2, 176.7, 172.6, 170.5, 157.7, 140.6, 84.6, 81.1, 73.6,
52.5, 48.5, 41.3, 37.9, 33.8, 31.2, 25.7, 24.4, 22.6, 22.4, 20.9, 14.0, 12.6,
10.1; IR (film) νmax 2935, 2873, 1787, 1727, 1249, 1170, 998 cm
−1;





yl Acetate (29). White amorphous solid (80 mg, 71%); [α]D
20 +44.34
(c 0.99, CHCl3);
1H NMR (500 MHz, CDCl3) δ 5.13 (d, J = 3.3 Hz,
1H), 4.82 (br d, J = 11.2 Hz, 1H), 4.06 (br s, 1H), 2.61 (ddd, J = 18.1,
13.6, 4.4 Hz, 1H), 2.34 (m, 3H), 2.29 (m, 1H), 2.25 (m, 1H), 2.15 (m,
1H), 2.08 (m, 1H), 1.96 (s, 6H), 1.62 (tt, J = 7.1, 7.1 Hz, 2H), 1.46
(dddd, J = 14.7, 14.7, 11.2, 3.6 Hz, 1H), 1.32 (m, 8H), 1.28 (d, J = 6.9
Hz, 3H), 1.24 (s, 3H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (126 MHz,
CDCl3) δ 201.2, 176.8, 172.7, 170.5, 157.7, 140.7, 84.7, 81.2, 73.6,
52.6, 48.6, 41.4, 37.9, 33.9, 31.8, 29.1, 29.1, 25.7, 24.8, 22.7, 22.6, 20.9,
14.2, 12.6, 10.1; IR (film) νmax 2929, 2859, 1785, 1734, 1728, 1233,





hexahydroazulen-4-yl Acetate (30). Yellow oil (118 mg, 98%);
[α]D
20 −79.09 (c 1.77, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.80
(br s, 1H), 5.30 (d, J = 2.9 Hz, 1H), 4.17 (br s, 1H), 3.67 (d, J = 9.7
Hz, 1H), 3.50 (d, J = 9.7 Hz, 1H), 2.89 (m, 1H), 2.55 (ddd, J = 14.7,
6.4, 3.4 Hz, 1H), 2.23 (ddd, J = 16.4, 6.5, 3.2 Hz, 1H), 2.14 (ddd, J =
14.1, 2.9, 2.7 Hz, 1H), 2.10 (s, 3H), 1.97 (s, 3H), 1.81 (d, J = 2.1 Hz,
3H), 1.29 (s, 3H), 1.24 (s, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s,
3H); 13C NMR (126 MHz, CDCl3) δ 202.3, 170.8, 169.8, 161.1,
157.1, 135.7, 119.2, 83.0, 76.4, 73.3, 68.5, 51.8, 40.2, 25.9, 25.1, 23.9,
22.8, 22.4, 20.9, 18.3, 8.5, −5.3; IR (film) νmax 3447, 2930, 1749, 1707,
1626, 1246, 1093, 837 cm−1; HRMS (APGC) calcd. for C25H41O7Si
[M + H]+ 481.2622; found 481.2610.
(3S,3aR,4S)-3-Butanoyloxy-7-((S)-1-((tert-butyldimethylsilyl)-
oxy)-2-hydroxypropan-2-yl)-1,4-dimethyl-2-oxo-2,3,3a,4,5,6-
hexahydroazulen-4-yl Acetate (31). Yellow oil (71 mg, 56%);
[α]D
20 −75.79 (c 2.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.80
(br s, 1H), 5.30 (d, J = 2.8 Hz, 1H), 4.17 (br s, 1H), 3.67 (d, J = 9.7
Hz, 1H), 3.50 (d, J = 9.7 Hz, 1H), 2.90 (m, 1H), 2.54 (ddd, J = 14.6,
6.4, 3.4 Hz, 1H), 2.32 (m, 2H), 2.22 (ddd, J = 16.8, 6.4, 3.2 Hz, 1H),
2.11 (ddd, J = 14.7, 11.7, 3.1 Hz, 1H), 1.96 (s, 3H), 1.81 (d, J = 2.6
Hz, 3H), 1.67 (tq, J = 7.4, 7.4 Hz, 2H), 1.28 (s, 3H), 1.24 (s, 3H), 0.97
(t, J = 7.4 Hz, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 202.4, 172.5, 170.8, 161.1, 157.1, 135.7, 119.2,
83.0, 76.4, 73.1, 68.5, 51.8, 40.2, 36.0, 25.9, 25.1, 24.0, 22.8, 22.4, 18.5,
18.3, 13.8, 8.5, −5.3; IR (film) νmax 3496, 2960, 2932, 2858, 1743,
1705, 1626, 1249, 1092, 836 cm−1; HRMS (APGC) calcd. for
C27H44O7Si [M]
+ 508.2856; found 508.2859.
(3S,3aR,4S)-3-Hexanoyloxy-7-((S)-1-((tert-butyldimethyl-
silyl)oxy)-2-hydroxypropan-2-yl)-1,4-dimethyl-2-oxo-
2,3,3a,4,5,6-hexahydroazulen-4-yl Acetate (32). Yellow oil (101
mg, 75%); [α]D
20 −88.73 (c 2.00, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 6.79 (br s, 1H), 5.28 (d, J = 2.8 Hz, 1H), 4.16 (br s, 1H),
3.66 (d, J = 9.7 Hz, 1H), 3.49 (d, J = 9.7 Hz, 1H), 2.89 (m, 1H), 2.54
(ddd, J = 14.5, 6.2, 3.2 Hz, 1H), 2.32 (m, 2H), 2.22 (ddd, J = 16.3, 6.4,
3.0 Hz, 1H), 2.11 (ddd, J = 16.5, 11.6, 3.1 Hz, 1H), 1.95 (s, 3H), 1.81
(d, J = 2.3 Hz, 3H), 1.63 (m, 2H), 1.32 (m, 4H), 1.28 (s, 3H), 1.23 (s,
3H), 0.87 (m, 12H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 202.4, 172.7, 170.8, 161.1, 157.1, 135.7, 119.2, 83.0, 76.4,
73.1, 68.5, 51.8, 40.2, 34.1, 31.3, 25.9, 25.1, 24.6, 23.9, 22.8, 22.4, 22.4,
18.3, 14.0, 8.5, −5.3; IR (film) νmax 3488, 2956, 2932, 2860, 1743,
1707, 1625, 1246, 1092, 838 cm−1; HRMS (APGC) calcd. for
C29H49O7Si [M + H]
+ 537.3248; found 537.3253.
(3S,3aR,4S)-7-((S)-1-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-
propan-2-yl)-1,4-dimethyl-3-octanoyloxy-2-oxo-2,3,3a,4,5,6-
hexahydroazulen-4-yl Acetate (33). Yellow oil (128 mg, 91%);
[α]D
20 −91.91 (c 1.53, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.80
(br s, 1H), 5.30 (d, J = 2.8 Hz, 1H), 4.16 (br s, 1H), 3.67 (d, J = 9.7
Hz, 1H), 3.50 (d, J = 9.7 Hz, 1H), 2.90 (m, 1H), 2.54 (ddd, J = 14.7,
6.5, 3.4 Hz, 1H), 2.34 (m, 2H), 2.23 (ddd, J = 16.3, 6.5, 3.2 Hz, 1H),
2.12 (ddd, J = 14.7, 11.6, 3.1 Hz, 1H), 1.96 (s, 3H), 1.82 (d, J = 2.1
Hz, 3H), 1.63 (m, 2H), 1.32 (m, 4H), 1.29 (s, 3H), 1.27 (m, 4H), 1.24
(s, 3H), 0.88 (m, 12H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR (126
MHz, CDCl3) δ 202.4, 172.7, 170.8, 161.1, 157.1, 135.8, 119.2, 83.0,
76.4, 73.1, 68.5, 51.8, 40.2, 34.2, 31.8, 29.2, 29.1, 25.9, 25.1, 25.0, 24.0,
22.8, 22.7, 22.5, 18.3, 14.2, 8.5, −5.3; IR (film) νmax 3467, 2930, 2859,
1740, 1706, 1624, 1248, 1092, 836 cm−1; HRMS (APGC) calcd. for
C31H53O7Si [M + H]
+ 565.3561; found 565.3549.
For the preparation of 36, a larger scale experiment was run for the
synthesis of 33: To a suspension of KMnO4 (746 mg, 4.720 mmol,
2.10 equiv) in dry benzene (50 mL) at 85 °C were added octanoic acid
(78.68 mmol, 12.5 mL, 35.0 equiv) and its anhydride (21.36 mmol, 6.3
mL, 9.50 equiv). The mixture was vigorously stirred until the
suspension changed from purple to brown (30 min), and then, 25
(950 mg, 2.248 mmol) was added (dissolved in the minimum amount
of dry benzene). The reaction was heated overnight at 85 °C. It is very
important to keep a vigorous stirring of the reaction. Then, the
mixture was cooled to room temperature and filtered through an
Al2O3/Celite pad rinsing with EtOAc. The solvent was evaporated
under reduced pressure, and the crude oil was purified by flash column
chromatography (gradient eluent from 0 to 20% EtOAc/hexanes) to
lead to compound 33 (1.09 g, 86% yield).
( 3S , 3aS , 6R , 6aR , 9bS ) - 3 , 6 , 9 -T r imethy l -2 , 8 -d ioxo -
2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-6-yl Ace-
tate (21). A solution of α-santonin 20 (500 mg, 2.03 mmol) in acetic
acid (200 mL) was irradiated in a quartz Hanovia reactor equipped
with a Hg medium pressure lamp for 5 h. Removal of the solvent
under vacuum and purification of the crude mixture by flash column
chromatography (40% EtOAc/hexanes) afforded O-acetylisophotosan-
tonic lactone 21 as a white solid (230 mg, 38% yield). Spectroscopic
data were in accordance with literature reported values.12
(3aS,4S)-7-((S)-1,2-Dihydroxypropan-2-yl)-1,4-dimethyl-2-
oxo-2,3,3a,4,5,6-hexahydroazulen-4-yl Acetate (24). A solution
of compound 2313 (570 mg, 2.30 mmol) in acetic acid (200 mL) was
irradiated and stirred in a quartz Hanovia reactor equipped with a Hg
medium pressure lamp for 2 h. Removal of the solvent under vacuum
and purification of the crude mixture by flash column chromatography
(75% EtOAc/hexanes) afforded the product 24 as a colorless oil (510




azulen-4-yl Acetate (25). Compound 24 (500 mg, 1.62 mmol) was
dissolved in dry THF (11 mL), and imidazole (330 mg, 4.86 mmol,
3.00 equiv) was added. The reaction mixture was cooled to 0 °C, and a
solution of TBDMSCl (366 mg, 2.43 mmol, 1.50 equiv) in dry THF
(5 mL) was added dropwise. The reaction was stirred for 3 h until
completion according to TLC analysis. The reaction was treated with
saturated aqueous NH4Cl (30 mL) and extracted with Et2O (3 × 15
mL). The combined organic layers were washed with brine and dried
over anhydrous Na2SO4, and the solvent was evaporated under
reduced pressure. Purification by flash column chromatography (30%
EtOAc/hexanes) afforded 25 as a yellow oil (678 mg, 99% yield):
[α]D
20 +28.19 (c 1.73, CHCl3);
1H NMR (500 MHz, CDCl3) δ 6.77 (s,
1H), 4.14 (br s, 1H), 3.68 (d, J = 9.6 Hz, 1H), 3.49 (d, J = 9.7 Hz,
1H), 2.93 (m, 1H), 2.59 (ddd, J = 15.1, 6.9, 2.7 Hz, 1H), 2.42 (dd, J =
19.1, 2.6 Hz, 1H), 2.37 (dd, J = 19.2, 2.6 Hz, 1H), 2.23 (ddd, J = 17.1,
6.8, 2.5 Hz, 1H), 2.00 (s, 3H), 1.94 (ddd, J = 14.8, 11.9, 2.7 Hz, 1H),
1.78 (d, J = 1.8 Hz, 3H), 1.28 (s, 3H), 1.13 (s, 3H), 0.87 (s, 9H), 0.07
(s, 3H), 0.06 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 208.5, 170.7,
163.5, 156.9, 137.7, 119.6, 84.7, 76.3, 68.5, 45.9, 40.1, 37.3, 25.9, 25.1,
22.9, 22.6, 22.4, 18.3, 8.4, −5.3; IR (film) νmax 3457, 2930, 2857, 1732,
1694, 1627, 1464, 1368, 1250, 1093, 837 cm−1; HRMS (APGC) calcd.
for C23H39O5Si [M + H]
+ 423.2567; found 423.2587.
(1S,8S,8aR)-8-Acetoxy-5-((S)-1,2-dihydroxypropan-2-yl)-3,8-
dimethyl-2-oxo-1,2,6,7,8,8a-hexahydroazulen-1-yl Octanoate
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(34). To a solution of compound 33 (163 mg, 0.288 mmol) in dry
THF (2 mL) at 0 °C was added TBAF (1 M solution in THF, 0.575
mL, 0.575 mmol, 2.00 equiv) dropwise. The mixture was stirred at
room temperature until completion according to TLC analysis (2 h).
The reaction was treated with saturated aqueous NH4Cl (5 mL) and
extracted with EtOAc (3 × 5 mL). Combined organic layers were
washed with brine and dried over anhydrous Na2SO4, and the solvent
was removed under vacuum. Purification by flash column chromatog-
raphy (70% EtOAc/hexanes) afforded product 34 as a yellow oil (74
mg, 61% yield): [α]D
20 −92.32 (c 1.92, CHCl3); 1H NMR (500 MHz,
CDCl3) δ 6.87 (s, 1H), 5.25 (d, J = 2.8 Hz, 1H), 4.22 (br s, 1H), 3.75
(d, J = 11.0 Hz, 1H), 3.52 (d, J = 11.0 Hz, 1H), 2.94 (m, 1H), 2.80 (br
s, OH), 2.57 (ddd, J = 14.8, 6.4, 3.4 Hz, 1H), 2.33 (m, 2H), 2.21 (ddd,
J = 16.4, 6.4, 3.2 Hz, 1H), 2.11 (ddd, J = 14.8, 11.7, 3.1 Hz, 1H), 1.96
(s, 3H), 1.82 (d, J = 2.1 Hz, 3H), 1.62 (tt, J = 7.4, 7.4 Hz, 2H), 1.34 (s,
3H), 1.28 (m, 8H), 1.24 (s, 3H), 0.86 (t, J = 7.0 Hz, 3H); 13C NMR
(126 MHz, CDCl3) δ 202.6, 172.8, 170.8, 160.9, 156.8, 136.0, 119.6,
83.0, 77.4, 73.3, 68.1, 51.7, 40.3, 34.1, 31.8, 29.2, 29.1, 25.2, 24.9, 24.1,
23.0, 22.7, 22.5, 14.2, 8.6; IR (film) νmax 3449, 2931, 2858, 1739, 1704,
1623, 1370, 1244, 1163, 1045 cm−1; HRMS (ESI) calcd. for C25H37O7
[M − H]− 449.2539; found 449.2539.
(3S,3aR,6S,6aR,7S,9bS)-6-Acetoxy-3,3a-dihydroxy-3,6,9-tri-
methyl-2,8-dioxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno-
[4,5-b]furan-7-yl Octanoate (36). Guaianediol 34 (70 mg, 0.155
mmol) was dissolved in a 20:2.5:1 acetone/tBuOH/H2O solution (8
mL, conc. 0.02 M) and then cooled at 0 °C. MeSO2NH2 (18 mg,
0.186 mmol, 1.20 equiv), NMO (22 mg, 0,186 mmol, 1.20 equiv), and
OsO4 (2 mg, 0.008 mmol, 0.05 equiv) were added. The reaction was
stirred for 24 h at room temperature and then treated with saturated
aqueous Na2SO3 solution (5 mL). After stirring for 40 min, water (5
mL) was added and the mixture was extracted with EtOAc (4 × 10
mL). The combined organic layers were dried over anhydrous
Na2SO4, and the solvent was removed under reduced pressure. This
material (75 mg) was used without further purification in the
subsequent step. Crude compound 35 (ca. 75 mg, 0.155 mmol) was
dissolved in a 1.3:1 MeCN/pH 7 buffer solution mixture (15 mL).
TEMPO (13 mg, 0.078 mmol, 0.50 equiv), NaClO2 (0.224 mL, 0.620
mmol, 4.00 equiv, 25% w/w in H2O), and NaClO (0.04 mL) were
added. The mixture was stirred at room temperature for 4 h, and then
aqueous saturated Na2SO3 solution (4 mL) was added. The pH was
set to 3 by adding aqueous 2 N HCl solution. The mixture was
extracted with EtOAc (4 × 10 mL) and washed with brine (15 mL).
After drying over anhydrous Na2SO4, the solvent was removed under
reduced pressure, affording pure compound 36 as a white amorphous
solid (48 mg, 65%): [α]D
20 −166.5 (c 0.30, CH3Cl); 1H NMR (400
MHz, CDCl3) δ 5.44 (br s, 1H), 5.14 (d, J = 3.6 Hz, 1H), 4.34 (br s,
1H), 2.78 (m, 1H), 2.59 (br s, OH), 2.34 (m, 2H), 2.25 (ddd, J = 13.7,
3.9, 3.9 Hz, 1H), 2.01 (m, 1H), 1.97 (d, J = 2.5 Hz, 3H), 1.95 (s, 3H),
1.88 (ddd, J = 15.6, 4.2, 4.2 Hz, 1H), 1.63 (m, 4H), 1.44 (s, 3H), 1.31
(s, 3H), 1.27 (m, 6H), 0.86 (t, J = 6.7 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 201.4, 175.6, 172.8, 170.6, 156.2, 141.7, 84.7, 82.5, 80.1,
77.8, 73.8, 52.7, 34.0, 31.8, 31.7, 29.1, 29.0, 24.9, 24.6, 22.8, 22.7, 19.9,
15.9, 14.2, 10.2; IR (film) νmax 3438, 2957, 2928, 2858, 1794, 1727,
1369, 1260, 1095, 1018, 804 cm−1; HRMS (ESI) calcd. for C25H35O9
[M − H]− 479.2281; found 479.2287.
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Chem. Res. 1999, 32, 837−845. (c) Davis, F. A.; Chen, B.-C. In
Stereoselective Synthesis; Helmchen, G., Hoffmann, R. W., Muzler, J.,
Schaumann, E., Eds.; Houben-Weyl Methods of Organic Chemistry;
George Thieme: Stuttgart, 1996; Vol. E21. (d) Fuhrhop, J.; Penalin, G.
Organic Synthesis, 2nd ed.; VCH: Weinheim, 1994. (e) Davis, F. A.;
Chen, B.-C. Chem. Rev. 1992, 92, 919−934. (f) Solujic, S.; Sukdolak,
S.; Ratkovic, Z. Tetrahedron Lett. 1991, 32, 4577−4578. (g) Williams,
G. J.; Hunter, N. R. Can. J. Chem. 1976, 54, 3830−3832.
(5) (a) Demir, A. S.; Jeganathan, A.; Watt, D. S. J. Org. Chem. 1989,
54, 4020−4022. (b) Voyle, M.; Dunlap, N. K.; Watt, D. S. J. Org.
Chem. 1983, 48, 3242−3245. (c) Dunlap, N. K.; Sabol, M. R.; Watt, D.
S. Tetrahedron Lett. 1984, 25, 5839−5842.
(6) Demir, A. S.; Reis, O.; Igdir, C. Tetrahedron 2004, 60, 3427−
3432.
(7) Heiba, E. I.; Dessau, R. M.; Koehl, W. J. J. Am. Chem. Soc. 1969,
91, 138−145.
(8) Demir, A. S.; Findik, H. Tetrahedron 2008, 64, 6196−6201.
(9) For a general introduction to experimental design in chemistry,
see: (a) Araujo, P. W.; Brereton, R. G. TrAC, Trends Anal. Chem. 1996,
15, 26−31. (b) Araujo, P. W.; Brereton, R. G. TrAC, Trends Anal.
Chem. 1996, 15, 63−70. (c) Carlson, R.; Carlson, J. E. Design and
Optimization in Organic Synthesis. In Data Handling and in Science
and Technology; Elsevier: Amsterdam, 2005. (d) Bezerra, M. A.;
Santelli, R. E.; Oliveira, E. P.; Villar, L. S.; Escaleira, L. A. Talanta
2008, 76, 965−977. (e) Leardy, R. Anal. Chim. Acta 2009, 652, 161−
172. (f) Murray, P. M.; Tyler, S. N. G.; Moseley, J. D. Org. Process Res.
Dev. 2013, 17, 40−46.
(10) (a) Lytton, J.; Westlin, M.; Hanley, M. R. J. Biol. Chem. 1991,
266, 17067−17071. (b) Inesi, G.; Sagara, Y. Arch. Biochem. Biophys.
1992, 298, 313−317. (c) Christensen, S. B.; Andersen, A.; Smitt, U.
W. Prog. Chem. Org. Nat. Prod. 1997, 71, 130−167. (d) Treiman, M.;
Carpersen, C.; Christensen, S. B. Trends Pharmacol. Sci. 1998, 19,
131−135. (e) Christensen, S. B.; Andersen, A.; Kromann, H.;
Treiman, M.; Tombal, B.; Denmeade, S. R.; Isaacs, J. T. Biorg. Med.
Chem. 1999, 7, 1273−1280. (f) Jacobsen, C. M.; Denmeade, S. R.;
The Journal of Organic Chemistry Article
dx.doi.org/10.1021/jo500915r | J. Org. Chem. 2014, 79, 6501−65096508
Isaacs, J. T.; Gady, A.; Olsen, C. E.; Christensen, S. B. J. Med. Chem.
2001, 44, 4696−4703.
(11) Baghbanzadeh, M.; Kappe, C. O. Aust. J. Chem. 2009, 62, 244−
249.
(12) Zang, W.; Luo, S.; Fang; Chen, Q.; Hu, H.; Jia, X.; Zhai, H. J.
Am. Chem. Soc. 2005, 127, 18−19.
(13) Manzano, F. L.; Guerra, F. M.; Moreno-Dorado, F. J.; Jorge, D.
Z.; Massanet, G. M. Org. Lett. 2006, 8, 2879−2882.
(14) Ghantous, A.; Gali-Muhtasib, H.; Vuorela, H.; Saliba, N. A.;
Darwiche, N. Drug Discovery Today 2010, 15, 668−678.
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